Real-life treatment practice for malignant pleural mesothelioma in Belgium
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 125, 258-264
Abstract
No abstract availableKeywords
Funding Information
- Foundation Against Cancer (FCC/STK)
This publication has 35 references indexed in Scilit:
- Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility studyThe Lancet Oncology, 2011
- Malignant pleural mesothelioma: The standard of care and challenges for future managementCritical Reviews in Oncology/Hematology, 2011
- Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trialEuropean Respiratory Journal, 2010
- Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesotheliomaEuropean Respiratory Journal, 2009
- EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivorsThorax, 2008
- Immortal Time Bias in PharmacoepidemiologyAmerican Journal of Epidemiology, 2007
- Ten traps for the unwary in surgical series: A case study in mesothelioma reportsThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of CanadaJournal of Clinical Oncology, 2005
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2003
- A Confidence Interval for the Median Survival Time1982